Hepatitis B prevention in Malaysia Presented by Dr A aisah binti Senin Head of Vaccine Preventable Diseases & Food and Water Bourne Diseases Disease Control Division, Ministry of Health Malaysia
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 NOTIFICATION RATE (NR) OF HEPATITIS B, 1990-2018 (June) per 100,000 population 25 NR 23.31 20 15 10 FOMEMA screening initiated NIP 1989 15.93 Notification of both acute & 12.94 12.59 chronic 12.6 16.24 5 0 Year
Hepatitis B Prevalence/incidence in Malaysia (2017) % Hep B (HBsAg) positives General population 0.015% (4991 Cases) -Notification Blood donors Pregnant women 0.0011% (386 Cases) 0.074% (368 Cases) 1400 Hepatitis B age distribution (2017) Healthcare workers Other. NA 1200 1000 800 600 Age 400 200 % HBeAg + 0 0y - 10y 11y - 20y 21y - 30y 31y - 40y 41y - 50y 51y - 60y 61y - 70y 71y - 80y 81y - 90y >90y Hep B pos pregnant women Data Not Available
Vaccination schedules 2018 Immunization schedule Disease TB (BCG) Polio Vaccine Name/brand Available free from the gov Recommended not for free Birth 1m 2m 3m 5m 6m 9m 12m 15m 18m 6Y 9/10Y 12/13y Diphtheria/Tetanus/pertussis/P olio/ Haemophilus Influenzae DTaP/IPV Hib (pentaxim) Hepatitis B X X X Rotavirus Measles or MMR Menigococcal Menegitis Pneumococcal Hepatitis A Chickenpox MMR (priorix) HPV Bi-valent Influenza RSV M MMR MMR
Vaccination coverage Immunization coverage Year (Before 2000) % Year (2000-2005) % Year (2006-2010) % Year (2016) % BCG DTP1 DTP3 HepB3 HepB_BD - - 82.57 94.89% 97.97% - - 81 99.82% 88.11% Hib3 IPV1 JapEnc MCV1 MCV2 PAB PCV1 PCV2 PCV3 Pol3 RCV1
Universal of hepatitis B in your country Hepatitis B Yes/no Target (who is vaccinate + age (if relevant)) Since/period Universal Yes Birth dose - 0,1,6 months all babies 1989 Risk groups Yes Healthcare worker, high risks gp 1990
Hepatitis B prevention- Immunization (combined/mono valent) Available hepatitis vaccines Disease NAME (producer) Target group Monovalent HepB All baby at birth within 24h Combined - - - Issues with hepatitis/ Combined (what are the problems in your country with use of combined Hep B ) Add text Opportunities (how do you think this issues can be solved)
Malaysia Extra information on birth dose(bd) Yes/no Since/period Coverage Birth dose in universal program Yes 1989 See next slide Issues with BD in your country Coverage - Return of coverage Birth dose lower than 3rd dose BCG Birth dose high WPRO Target for emtct for Hep B, HIV and Siphylis 2018-2030, is seroprevalence among children <0.1 % among children (Impact target) and process target of birth and 3rd dose of >95% and >95% coverage of antenatal testing of HBsAg. Successes with BD in your country Malaysia achieved WHO control goal of <1 % Seroprevalence rate of 0.3% among children
IMMUNISATION COVERAGE HEP B BIRTH DOSES 105 BCG HBV BD HBV3 100 95 90 85 80 75 70 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
This is a template that will be distributed among the participants of the groups discussions in the VHPB Hanoi 2018 meeting on Prevention and control of hepatitis B with combined vaccines and birth dose The goal of this template is to get streamlined information, that can easily be compared, among participating countries. Please take this slides as a guideline, not as a fixed template. More information is always welcome but don t exceed 10 slides Present only information for your specific country (no global neither Asian region information is requested) See also some additional notes in the note box of each slide